Analyst firms · Jefferies · TEVA
Jefferies TEVA price target and rating history
Teva Pharmaceutical Industries Limited (TEVA) · Health Care
Jefferies rates Teva Pharmaceutical Industries Limited (TEVA) Buy with a $14 price target, as of its latest action on Jan 23, 2024. It has published 3 rating actions on TEVA since October 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a TEVA price target in the last 12 months, the median target is $47.50.
- Current rating
- Buy
- Price target
- $14
- Median target, all firms
- $47.50
- Actions on TEVA
- 3
Jefferies price target on TEVA
Every Jefferies rating on TEVA
- Jan 23, 2024
- Jan 19, 2023
- Oct 21, 2022
How other firms rate TEVA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Buy | $52 | Nov 2, 2026 |
| TD Cowen | Buy | $55 | Oct 1, 2026 |
| Oppenheimer | Outperform | $50 | Sep 23, 2026 |
| Leerink Partners | Outperform | $45 | Sep 9, 2026 |
| Barclays | Overweight | $35 | Dec 9, 2025 |
| Scotiabank | Sector Outperform | $35 | Dec 5, 2025 |
Questions about Jefferies and TEVA
- What is Jefferies's price target for TEVA?
- Jefferies's latest stated price target for Teva Pharmaceutical Industries Limited (TEVA) is $14, from its action on Jan 23, 2024.
- What is Jefferies's rating on TEVA?
- Jefferies rates TEVA Buy, a bullish rating, as of Jan 23, 2024.
- When did Jefferies last change its view on TEVA?
- On Jan 23, 2024, Jefferies upgrades to Buy from Hold, price target $10 to $14.
- How does Jefferies's TEVA target compare with other analysts?
- Across 6 firms with a TEVA price target in the last 12 months, the median target is $47.50.
More TEVA rating histories
All Jefferies ratingsTEVA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.